Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Context Therapeutics Reports Second Quarter 2025 Operating and Financial Results
-
MediaAlpha Announces Second Quarter 2025 Financial Results
-
Alto Ingredients, Inc. Reports Second Quarter 2025 Results
-
Gulf Island Reports Second Quarter 2025 Results
-
Cytek Biosciences Reports Second Quarter 2025 Financial Results
-
Inotiv Reports Third Quarter Financial Results for Fiscal 2025 and Provides Business Update
-
Cerence Announces Third Quarter Fiscal 2025 Results; Revenue and Profitability Exceed High End of Guidance
-
GEN Restaurant Group Announces Second Quarter 2025 Financial Results
-
ARKO Corp. Reports Second Quarter 2025 Results
-
Oportun Achieves Third Straight Quarter of GAAP Profitability and Raises Full-Year 2025 Outlook
-
Zentalis Pharmaceuticals Reports Second Quarter 2025 Financial Results and Operational Progress
-
electroCore Announces Second Quarter 2025 Financial Results
-
Neumora Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update
-
Aligos Therapeutics Reports Recent Business Progress and Second Quarter 2025 Financial Results
-
Potbelly Corporation Reports Results for Second Fiscal Quarter 2025
-
AVITA Medical Announces Appointment of Michael Tarnoff, MD, FACS, to its Board of Directors and Transition of Board Chair Role to Cary Vance
-
Open Lending Reports Second Quarter 2025 Financial Results
-
Vaxart to Host Second Quarter 2025 Business Update and Financial Results Conference Call on August 13
-
Pennant Reports Second Quarter 2025 Results
-
Ormat Technologies Reports Second Quarter 2025 Financial Results
-
MediaAlpha Reaches Settlement with FTC
-
EverCommerce Announces Second Quarter 2025 Financial Results
-
American Coastal Insurance Corporation Reports Financial Results for Its Second Quarter Ended June 30, 2025
-
SuRo Capital Corp. Reports Second Quarter 2025 Financial Results
-
Magnite Reports Second Quarter 2025 Results
-
Fortinet Reports Second Quarter 2025 Financial Results
-
Star Bulk Carriers Corp. Reports Financial Results for the Second Quarter of 2025, and Declares Quarterly Dividend of $0.05 Per Share
-
Berry Corporation Announces Second Quarter 2025 Financial and Operational Results, Continued Debt Reduction and Quarterly Dividend
-
Exagen Inc. to Participate in Third Quarter Investor Conferences
-
Vaxcyte Reports Second Quarter 2025 Financial Results and Provides Business Update, Highlighting Key Clinical and Regulatory Progress for VAX-31, a Potential Best-in-Class Pneumococcal Conjugate Vacci
-
Assembly Biosciences Reports Second Quarter 2025 Financial Results and Recent Updates
-
Talkspace to Participate in Upcoming Investor Conference
-
Encore Capital Group Announces Second Quarter 2025 Financial Results
-
The Honest Company Reports Second Quarter 2025 Results
-
Amplify Energy Announces Strategic Initiatives Update, Second Quarter 2025 Results, and Updated Full-Year 2025 Guidance
-
Remitly Reports Second Quarter 2025 Results Above Outlook and Raises Full Year 2025 Outlook
-
Snail, Inc. Sets Second Quarter 2025 Conference Call for Wednesday, August 13, 2025 at 4:30 p.m. ET
-
MaxCyte Reports Second Quarter 2025 Financial Results and Updates Full Year 2025 Guidance
-
LiveRamp Announces Results for First Quarter FY26
-
Assembly Biosciences Reports Interim Phase 1a Data from Clinical Study of Oral Entry Inhibitor Candidate ABI-6250 for Hepatitis Delta Virus
-
HilleVax Reports Second Quarter 2025 Financial Results
-
Seer Reports Second Quarter 2025 Financial Results and Reiterates Full Year 2025 Outlook
-
Senseonics Holdings, Inc. Reports Second Quarter Financial Results
-
ADMA Biologics Announces Second Quarter 2025 Financial Results and Provides Business Update
-
Crane NXT Reports Second Quarter 2025 Results
-
Tarsus Reports Second Quarter 2025 Financial Results and Recent Business Achievements
-
Fractyl Health to Report Second Quarter 2025 Financial Results and Provide Business Updates on August 12, 2025, and Will Participate in an Upcoming Investor Conference
-
BBSI Reports Strong Second Quarter 2025 Financial Results
-
red violet Announces Second Quarter 2025 Financial Results
-
Artiva Biotherapeutics Reports Second Quarter 2025 Financial Results, Recent Business Highlights

